Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Glenmark...

    Tag: Glenmark Pharmaceuticals

    You Searched For "Glenmark Pharmaceuticals"
    Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

    Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

    Medical Dialogues Bureau8 May 2019 3:45 AM GMT
    Yasir Rawjee joins Glenmark Life Sciences from Mylan, where most recently he was the Head of Global API Operations, Glenmark Pharmaceuticals said in a...
    Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen

    Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen

    Meghna A Singhania30 April 2019 4:46 AM GMT
    Glenmark will commercialize Remogliflozin in India under the brand names 'Remo' and 'Remozen'.Mumbai: In a major relief to diabetics, Glenmark...
    Diabetes Treatment: CDSCO expert panel marketing authorization Nod to Glenmark

    Diabetes Treatment: CDSCO expert panel marketing authorization Nod to Glenmark's SGLT2 Inhibitor Remogliflozin etabonate

    Meghna A Singhania31 March 2019 8:09 AM GMT
    New Delhi: Mumbai-based Glenmark Pharmaceuticals Limited recently received the permission from the IND Committee of the Central Drugs Standard...
    Glenmark gets USFDA nod for generic version of acne treatment gel

    Glenmark gets USFDA nod for generic version of acne treatment gel

    Farhat Nasim17 March 2019 3:51 AM GMT
    New Delhi: Glenmark Pharmaceuticals Friday said it has received final approval from the US health regulator for its generic version of BenzaClin gel...
    Glenmark gets tentative USFDA nod for Abiraterone Acetate tablets

    Glenmark gets tentative USFDA nod for Abiraterone Acetate tablets

    Medical Dialogues Bureau24 Jan 2019 4:00 AM GMT
    Glenmark Pharmaceuticals Inc USA has been granted tentative approval by the United States Food and Drug Administration for Abiraterone Acetate tablets...
    Glenmark inks pact with private equity firm True North

    Glenmark inks pact with private equity firm True North

    Ruby Khatun Khatun15 Aug 2018 5:00 AM GMT
    New Delhi: Glenmark Pharmaceuticals said it has entered into a collaboration with private equity firm True North for its orthopaedic and pain...
    DRL recalls 80,000 plus bottles of Atorvastatin from US due to quality concerns

    DRL recalls 80,000 plus bottles of Atorvastatin from US due to quality concerns

    Medical Dialogues Bureau9 Feb 2018 5:58 AM GMT
    HYDERABAD: Dr. Reddy's Laboratories has initiated a voluntary recall of over 80,000 bottles of its drug Atorvastatin Calcium Tablets 10mg, 20mg and...
    Glenmark completes phase 3 study for nasal spray

    Glenmark completes phase 3 study for nasal spray

    Ruby Khatun Khatun15 Dec 2017 4:45 AM GMT
    New Delhi: Glenmark Pharmaceuticals said it has completed phase 3 study of its investigational fixed-dose combination nasal spray and plans to submit...
    Glenmark gets USFDA nod for contraceptive tablets

    Glenmark gets USFDA nod for contraceptive tablets

    Ruby Khatun Khatun22 Nov 2017 5:00 AM GMT
    New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Loestrin tablets used to...
    Glenmark Pharmaceuticals launches nicotine gum Kwitz

    Glenmark Pharmaceuticals launches nicotine gum Kwitz

    Ruby Khatun Khatun18 Nov 2017 5:00 AM GMT
    New Delhi: Glenmark Pharmaceuticals said it has launched nicotine replacement therapy product Kwitz that helps smokers quit smoking.Kwitz nicotine gum...
    Glenmark expects generics to drive growth over next 3 yrs

    Glenmark expects generics to drive growth over next 3 yrs

    Ruby Khatun Khatun25 Sep 2017 5:07 AM GMT
    Mumbai: Pharma firm Glenmark Pharmaceuticals has said its pipeline of specialty and innovative products over the next three to four years is expected...
    Glenmark gets USFDA nod for chest pain tablets

    Glenmark gets USFDA nod for chest pain tablets

    Ruby Khatun Khatun22 Sep 2017 5:17 AM GMT
    New Delhi: Glenmark Pharmaceuticals on Wednesday said its US arm has received final approval from USFDA for its Nitroglycerin sublingual tablets used...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X